Experion is a Federally Licensed Cannabis company focused on distributing high quality cannabis products. With its state of the art facility, ability to source, process and distribute products nationally, is there opportunity? Plenty.
The underlying reason why investors originally invested in this sector remains the same: cannabis is and will continue to be a thriving multi-billion-dollar industry, with significant growth potential year over year.
Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024
The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025
Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025
(TSXV:EXP) (OTCQB:EXPFF)
$0.0950
CURRENT ($)
0.01
24-hour Change ($)
5.56%
24-hour Change (%)
Driving shareholder value through the distribution of quality cannabis products.
Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts
Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis
Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers
Expertise, skill set and network to take advantage of global export opportunities
Experion Partners with Leading National Sales Agency, Velvet Management
September 21st, 2020
Experion Launches Flagship Brand Citizen Stash in Ontario
September 14th, 2020
Experion Provides Third Quarter 2020 Strategic Update
September 8th, 2020
Experion Set to Introduce Vegan Gummies Under Citizen Stash
August 25th, 2020
Experion Reports Record Revenue Growth in Q2 and Reports on Financial and Operational Highlights
July 29th, 2020
Experion Holdings Announces New Chairman of the Board
July 28th, 2020
Projected spend Adult-use cannabis in Canada by 2024 (USD)
Potential size of the Medical marijuana market in Canada by 2025 (USD)
Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)
Global cannabis spend by the end of 2025 (USD)
As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform
LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.
You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.
